[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zevra Therapeutics Inc (ZVRA)

Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 657,359
  • Shares Outstanding, K 59,115
  • Annual Sales, $ 106,470 K
  • Annual Income, $ 83,230 K
  • EBIT $ 56 M
  • EBITDA $ 115 M
  • 60-Month Beta 0.88
  • Price/Sales 6.14
  • Price/Cash Flow 11.68
  • Price/Book 3.17

Options Overview Details

View History
  • Implied Volatility 63.52% (+8.13%)
  • Historical Volatility 43.82%
  • IV Percentile 7%
  • IV Rank 4.38%
  • IV High 339.85% on 03/03/26
  • IV Low 50.87% on 05/22/25
  • Expected Move (DTE 1) 0.81 (7.21%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 1,069
  • Volume Avg (30-Day) 1,254
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 56,565
  • Open Int (30-Day) 49,052
  • Expected Range 10.39 to 12.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.08
  • Number of Estimates 3
  • High Estimate $0.10
  • Low Estimate $0.06
  • Prior Year $-0.06
  • Growth Rate Est. (year over year) +233.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.48 +23.69%
on 04/29/26
11.86 -1.18%
on 05/11/26
+1.93 (+19.71%)
since 04/14/26
3-Month
8.42 +39.19%
on 03/06/26
11.86 -1.18%
on 05/11/26
+3.22 (+37.88%)
since 02/13/26
52-Week
7.16 +63.69%
on 09/17/25
13.16 -10.94%
on 07/15/25
+3.58 (+43.98%)
since 05/14/25

Most Recent Stories

More News
Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference

BOSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease,...

ZVRA : 11.75 (+5.67%)
Zevra Therapeutics: Q1 Earnings Snapshot

Zevra Therapeutics: Q1 Earnings Snapshot

ZVRA : 11.75 (+5.67%)
Zevra Reports First Quarter 2026 Financial Results and Corporate Update

Q1 2026 net revenue of $36.2 million , a 78% increase over Q1 2025 Completed $50.0 million sale of SDX portfolio to Commave Therapeutics Operational execution fueled strong cash position...

ZVRA : 11.75 (+5.67%)
Zevra's Rare Disease Portfolio May Finally Have Enough Market Traction to Revalue

Barchart Research What to Expect from ZVRA Earnings ZVRA Generated May 5, 2026 Current Price $10.61 EPS Estimate $$0.06 Consensus Rating Strong Buy Average Move 7.85% Zevra's Rare Disease Portfolio May...

ZVRA : 11.75 (+5.67%)
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call

BOSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease,...

ZVRA : 11.75 (+5.67%)
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, March 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease,...

ZVRA : 11.75 (+5.67%)
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million

BOSTON, March 16, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease,...

ZVRA : 11.75 (+5.67%)
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

Program to expand access to exome sequencing to help clinicians confirm diagnosis and guide clinical decision-making in NPC

ZVRA : 11.75 (+5.67%)
WGS : 39.90 (+2.47%)
Zevra Therapeutics: Q4 Earnings Snapshot

Zevra Therapeutics: Q4 Earnings Snapshot

ZVRA : 11.75 (+5.67%)
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results

Q4 net revenue of $34.1 million, representing 31% growth quarter-over-quarter FY 2025 net revenue of $106.5 million , driven by growth in MIPLYFFA ® net revenue to $87.4 million...

ZVRA : 11.75 (+5.67%)

Business Summary

Zevra Therapeutics is a rare disease company melding science, data, and patient need to create transformational therapies for diseases with limited or no treatment options. Zevra Therapeutics, formerly known as KemPharm Inc., is based in CELEBRATION, Fla.

See More

Key Turning Points

3rd Resistance Point 11.68
2nd Resistance Point 11.47
1st Resistance Point 11.29
Last Price 11.75
1st Support Level 10.90
2nd Support Level 10.69
3rd Support Level 10.51

See More

52-Week High 13.16
Last Price 11.75
Fibonacci 61.8% 10.87
Fibonacci 50% 10.16
Fibonacci 38.2% 9.45
52-Week Low 7.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.